Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

SPPI

Spectrum Pharmaceuticals (SPPI)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPPI
DataOraFonteTitoloSimboloCompagnia
09/11/202323:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SPPISpectrum Pharmaceuticals Inc
28/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SPPISpectrum Pharmaceuticals Inc
26/09/202323:23Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SPPISpectrum Pharmaceuticals Inc
26/09/202323:17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SPPISpectrum Pharmaceuticals Inc
01/08/202323:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SPPISpectrum Pharmaceuticals Inc
01/08/202314:42Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:SPPISpectrum Pharmaceuticals Inc
01/08/202301:27GlobeNewswire Inc.Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals TransactionNASDAQ:SPPISpectrum Pharmaceuticals Inc
27/07/202323:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPPISpectrum Pharmaceuticals Inc
27/07/202322:01GlobeNewswire Inc.Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum PharmaceuticalsNASDAQ:SPPISpectrum Pharmaceuticals Inc
20/07/202314:17Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SPPISpectrum Pharmaceuticals Inc
20/07/202313:00Business WireIndependent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.NASDAQ:SPPISpectrum Pharmaceuticals Inc
23/06/202322:32Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SPPISpectrum Pharmaceuticals Inc
15/06/202322:29Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SPPISpectrum Pharmaceuticals Inc
31/05/202301:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SPPISpectrum Pharmaceuticals Inc
17/05/202313:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SPPISpectrum Pharmaceuticals Inc
17/05/202313:00Business WireSpectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:SPPISpectrum Pharmaceuticals Inc
11/05/202322:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SPPISpectrum Pharmaceuticals Inc
09/05/202313:17Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SPPISpectrum Pharmaceuticals Inc
09/05/202313:00Business WireSpectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate UpdateNASDAQ:SPPISpectrum Pharmaceuticals Inc
01/05/202322:42Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SPPISpectrum Pharmaceuticals Inc
26/04/202312:01Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SPPISpectrum Pharmaceuticals Inc
25/04/202312:00GlobeNewswire Inc.Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR TransactionNASDAQ:SPPISpectrum Pharmaceuticals Inc
31/03/202322:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SPPISpectrum Pharmaceuticals Inc
22/03/202313:00Business WireSpectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate UpdateNASDAQ:SPPISpectrum Pharmaceuticals Inc
17/03/202312:00Business WireSpectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate UpdateNASDAQ:SPPISpectrum Pharmaceuticals Inc
14/02/202319:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SPPISpectrum Pharmaceuticals Inc
13/02/202323:32Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:SPPISpectrum Pharmaceuticals Inc
08/02/202313:00Business WireSpectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid ServicesNASDAQ:SPPISpectrum Pharmaceuticals Inc
03/02/202311:45PR Newswire (US)SPPI SHAREHOLDER ALERT: Jakubowitz Law Reminds Spectrum Shareholders of a Lead Plaintiff Deadline of February 3, 2023NASDAQ:SPPISpectrum Pharmaceuticals Inc
01/02/202311:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 3, 2023 - (NASDAQ: SPPI)NASDAQ:SPPISpectrum Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SPPI
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network